Audio By Carbonatix
Testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears, the World Health Organization (WHO) says.
Trials in several countries are being "temporarily" suspended as a precaution, the agency said on Monday.
It comes after a recent medical study suggested the drug could increase the risk of patients dying from Covid-19.
President Donald Trump has said he is taking the drug to ward off the virus.
The US president has repeatedly promoted the anti-malarial drug, against medical advice and despite warnings from public health officials that it could cause heart problems.
Last week, a study in medical journal The Lancet said there were no benefits to treating coronavirus patients with hydroxychloroquine, and that taking it might even increase the number of deaths among those in hospital with the disease.
Hydroxychloroquine is safe for malaria, and conditions like lupus or arthritis, but no clinical trials have recommended its use for treating Covid-19.
The WHO, which is running clinical trials of various drugs to assess which might be beneficial in treating the disease, has previously raised concerns over reports of individuals self-medicating and causing themselves serious harm.
On Monday, officials at the UN health agency said hydroxychloroquine would be removed from those trials pending a safety assessment.
The Lancet study involved 96,000 coronavirus patients, nearly 15,000 of whom were given hydroxychloroquine - or a related form chloroquine - either alone or with an antibiotic.
The study found that the patients were more likely to die in hospital and develop heart rhythm complications than other Covid patients in a comparison group.
The death rates of the treated groups were: hydroxychloroquine 18%; chloroquine 16.4%; control group 9%. Those treated with hydroxychloroquine or chloroquine in combination with antibiotics had an even higher death rate.
The researchers warned that hydroxychloroquine should not be used outside of clinical trials.
Latest Stories
-
British Council advocates language-responsive education to improve learning outcomes
11 minutes -
Iran begins public mourning for Ayatollah killed in February
1 hour -
World Cup exit: Asamoah Gyan says Ghana’s performance was below par
2 hours -
‘They took their chance; we didn’t’ — Jerome Opoku reflects on Ghana’s World Cup exit
2 hours -
Lyrical Joe inspires resilience on new single ‘Free Minds’ featuring King Paluta
2 hours -
Black Stars need time to adapt to Queiroz’s philosophy — Jordan Ayew
3 hours -
UBIDS LLB Class demands reinstatement of 33 omitted graduands ahead of ceremony
3 hours -
Black Stars lost organisation after Senaya’s injury – Carlos Queiroz
3 hours -
Ghana’s World Cup dream ends as Arias fires Colombia into last 16
4 hours -
NDC signs cooperation accord with Russia’s United Russia Party
4 hours -
Taylor Swift and Travis Kelce wed in NYC in ceremony officiated by Adam Sandler
5 hours -
NDPC discusses proposed Black Star Stadium project with Western Regional Minister
5 hours -
NDPC begins review of planning guidelines to strengthen regional and district development coordination
5 hours -
16% of Accra’s drainage buffer zones lost to encroachment — GARID
5 hours -
Flood disaster: Death toll hits 34 — NADMO
6 hours